Elanco Animal Health (ELAN) Receivables (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Receivables data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 8.87% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 8.87% YoY), and the FY2025 full-year result was $940.0 million, up 6.09% from the prior year.
• Receivables grew to $1.2 billion in Q1 2026, from $940.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $1.3 billion in Q1 2023 to a low of $886.0 million in Q4 2024.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables climbed 10.41% in 2023 and fell 20.35% in 2024, its largest moves.
• Tracing ELAN's Receivables over 5 years: stood at $1.0 billion in 2022, then increased by 0.8% to $1.0 billion in 2023, then retreated by 12.28% to $886.0 million in 2024, then grew by 6.09% to $940.0 million in 2025, then grew by 22.77% to $1.2 billion in 2026.
• Business Quant data shows ELAN's Receivables at $1.2 billion in Q1 2026, $940.0 million in Q4 2025, and $975.0 million in Q3 2025.